Stockreport

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial

Kairos Pharma, Ltd.  (KAPA) 
PDF ENV105 can potentially address resistance in a wide range of cancers as they become resistant to standard treatments. LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. [Read more]